癌细胞中的SOCS1表达:在促进抗瘤免疫力方面的潜在作用
Subburaj Ilangumaran1, Yirui Gui1, Akhil Shukla1
1Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada.
Frontiers in immunology
|February 28, 2024
概括
细胞因子信号传递抑制剂1 (SOCS1) 通过调节免疫反应,起到瘤抑制作用. 本综述探讨了瘤细胞中的SOCS1如何通过外部机制影响抗瘤免疫力,影响癌症的进展.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 细胞因子信号传递抑制剂1 (SOCS1) 是免疫细胞反应的关键调节剂,也是已知的瘤抑制剂.
- 在瘤细胞中失去SOCS1会增加瘤的攻击性,而在T细胞中抑制SOCS1会增加抗瘤免疫力.
- 目前的研究主要集中在SOCS1在瘤细胞中的内在功能,以抑制瘤.
研究的目的:
- 审查SOCS1细胞外部调节抗瘤免疫反应的证据.
- 讨论瘤细胞SOCS1影响免疫系统的直接和间接机制.
- 探索这些发现对癌症免疫疗法的影响.
主要方法:
- 文献综述和对SOCS现有研究的综合研究1.
- 对研究SOCS1在瘤细胞和免疫细胞中的作用的分析.
- 讨论SOCS1行动的拟议直接和间接机制.
主要成果:
- 有证据表明,瘤细胞表达的SOCS1可以通过外部途径调节抗瘤免疫力.
- SOCS1可能直接或间接影响免疫细胞功能和瘤微环境.
- 了解这些外部作用对于开发有效的癌症疗法至关重要.
结论:
- SOCS1的功能超越了瘤细胞内在的作用,显著影响抗瘤免疫力.
- 向瘤细胞中的SOCS1可以提供新的策略来增强免疫媒介癌症控制.
- 为了推进癌症治疗,需要对SOCS1的外部机制进行进一步的研究.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


